PPARγPromotes Growth and Invasion of Thyroid Cancer Cells

Authors:

Abstract
Undifferentiated (anaplastic) thyroid cancer (ATC) is one of the most aggressive human malignancies and no effective therapy is currently available. We show here that PPARγlevels are elevated in cells derived from ATC. Depletion of PPARγin HTh74 ATC cells resulted in decreased cell growth, cell cycle arrest and a reduction in pRb and cyclin A and B1 levels. We further showed that both flank and orthotopic thyroid tumors derived from PPARγ-depleted cells grew more slowly than PPARγ-expressing cells. When PPARγwas overexpressed in more differentiated thyroid cancer BCPAP cells which lack PPARγ, there was increased growth and raised pRb and cyclin A and B1 levels. Finally, PPARγdepletion in ATC cells decreased their invasive capacity whereas overexpression in PTC cells increased invasiveness. These data suggest that PPARγmay play a detrimental role in thyroid cancer and that targeting it therapeutically may lead to improved treatment of advanced thyroid cancer.
Funding Information
  • National Cancer Institute (R01 CA100560)
  • Mary Rossick Kern and Jerome H. Kern Endowment for Endocrine Neoplasms Research (R01 CA100560)

This publication has 42 references indexed in Scilit: